Zura Bio
Henderson · Founded 2022
About Zura Bio
Zura Bio is a clinical-stage, multi-asset biotechnology company dedicated to developing novel dual-pathway antibody medicines for the treatment of serious autoimmune and inflammatory disorders. The company’s approach’targeting two disease-driving mechanisms at once’is designed to offer potentially greater efficacy, safety, and dosing advantages over single-target treatments.
Company Facts
- Founded: 2022
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1M – $10M
- Total funding: $317.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2026)
- Ticker: nasdaq:ZURA
- Website: https://zurabio.com/
- Phone: +1 702-825-9872
Industries & Categories
Biopharma, Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/zura-bio-23383 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.